Birth-control pills disrupt women’s stress response, study shows

New drugs in the US were, on av­er­age, ap­proved months be­fore win­ning ap­proval in the EU, ac­cord­ing to new da­ta from The IQVIA In­sti­tute for

As I-Mab Bio­phar­ma em­barks on its next chap­ter as a ful­ly US-based com­pa­ny, it’s part­ing ways with more ex­ec­u­tives from the old era. Chief Busi­ness